ABEO
Price
$7.13
Change
-$0.10 (-1.38%)
Updated
Aug 15 closing price
Capitalization
364.75M
92 days until earnings call
MLEC
Price
$2.46
Change
+$0.02 (+0.82%)
Updated
Aug 15 closing price
Capitalization
9.85M
71 days until earnings call
Interact to see
Advertisement

ABEO vs MLEC

Header iconABEO vs MLEC Comparison
Open Charts ABEO vs MLECBanner chart's image
Abeona Therapeutics
Price$7.13
Change-$0.10 (-1.38%)
Volume$1.15M
Capitalization364.75M
Moolec Science SA
Price$2.46
Change+$0.02 (+0.82%)
Volume$9.87K
Capitalization9.85M
ABEO vs MLEC Comparison Chart in %
Loading...
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABEO vs. MLEC commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEO is a Hold and MLEC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (ABEO: $7.13 vs. MLEC: $2.46)
Brand notoriety: ABEO and MLEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABEO: 131% vs. MLEC: 12%
Market capitalization -- ABEO: $364.75M vs. MLEC: $9.85M
ABEO [@Biotechnology] is valued at $364.75M. MLEC’s [@Biotechnology] market capitalization is $9.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABEO’s FA Score shows that 0 FA rating(s) are green whileMLEC’s FA Score has 0 green FA rating(s).

  • ABEO’s FA Score: 0 green, 5 red.
  • MLEC’s FA Score: 0 green, 5 red.
According to our system of comparison, ABEO is a better buy in the long-term than MLEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABEO’s TA Score shows that 6 TA indicator(s) are bullish while MLEC’s TA Score has 4 bullish TA indicator(s).

  • ABEO’s TA Score: 6 bullish, 4 bearish.
  • MLEC’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, ABEO is a better buy in the short-term than MLEC.

Price Growth

ABEO (@Biotechnology) experienced а +13.90% price change this week, while MLEC (@Biotechnology) price change was -16.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

ABEO is expected to report earnings on Nov 17, 2025.

MLEC is expected to report earnings on Oct 27, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABEO($365M) has a higher market cap than MLEC($9.85M). ABEO YTD gains are higher at: 28.007 vs. MLEC (-69.234). MLEC has higher annual earnings (EBITDA): -5.24M vs. ABEO (-36.93M). ABEO has more cash in the bank: 84.2M vs. MLEC (926K). MLEC has less debt than ABEO: MLEC (22.1M) vs ABEO (24M). MLEC has higher revenues than ABEO: MLEC (7.83M) vs ABEO (0).
ABEOMLECABEO / MLEC
Capitalization365M9.85M3,707%
EBITDA-36.93M-5.24M704%
Gain YTD28.007-69.234-40%
P/E Ratio11.14N/A-
Revenue07.83M-
Total Cash84.2M926K9,093%
Total Debt24M22.1M109%
FUNDAMENTALS RATINGS
ABEO: Fundamental Ratings
ABEO
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABEOMLEC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
45%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 17 days ago
60%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
Z85.11-0.16
-0.19%
Zillow Group
SIGA8.50-0.08
-0.93%
SIGA Technologies
FA16.48-0.34
-2.02%
First Advantage Corp
PLX1.48-0.04
-2.63%
Protalix BioTherapeutics
BFRI0.93-0.04
-3.73%
Biofrontera

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with WINT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
+0.67%
WINT - MLEC
49%
Loosely correlated
-0.85%
CTMX - MLEC
42%
Loosely correlated
+8.52%
AAVXF - MLEC
38%
Loosely correlated
N/A
ABEO - MLEC
36%
Loosely correlated
-1.38%
ABVC - MLEC
31%
Poorly correlated
+8.55%
More